Company Profile

Cisen Pharmaceutical Co., Ltd., an integrated chemical production enterprise, developed from Jining third pharmaceutical factory founded in 1970, restructured to form Shandong Lukang Cisen Pharmaceutical Co., Ltd. in 1998, officially changed its name in July 1st,2011. Cisen has developed into a modern pharmaceutical company, with 4 subsidiaries (branches) throughout China, all this rapid development took place within recent 16 years.

According to the 2013 sales ranking of chemical industry enterprises 100, Cisen ranked Top 44. Production and sales of the infusion solution ranked the third in China.

Cisen Pharmaceutical is specialized in manufacture and sale of more than 400 different products, including IV solutions, lyophilized, sterile powders for injections, small volume parenteral, tablets, capsules, ointment, eye(ear) drops, API and so on.

In the future, Cisen will continue to increase R&D efforts in sterile preparation, to secure its technology and product advantage; secondly, the cGMP workshop will ensure new products smoothly production and be approved by U.S. FDA in 2015; thirdly, we will emphasize the R&D of antineoplastic, narcotic, nutriceutical, endocrine system, cardiovascular and cerebrovascular drugs, improving the management level of the preparation quality, realizing its internationalization. Cisen Pharmaceutical will strive to be one of the largest pharmaceutical manufacturers in China, featuring the largest scale, the widest range of product specification, the highest profit margin as well as the strongest competitiveness.


more >

Year of Establishment: 1970

Total Assets(USD): 250,000,000 To 499,999,999

Total Number of Staff: more than 500

Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights: Adefovir ester (raw materials, and tablet) AnPuLe set and its hydrochloride eye drops Oxaliplatin into mannitol injection Azithromycin and Glucose Injection Clindamycin phosphate and sodium chloride injection Drug combination containing compound 11 acid zinc content in the preparation of curing of the application of the drug Adefovir ester and polyethylene glycol communion and its preparation method Drug combination containing 11 acid zinc content in the preparation of curing of the application of the drug A pharmaceutical preparation and its preparation method

Certificates/Standards View More
Send your message to this supplier
  • From:
  • To:
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification: